Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous neurodevelopmental disorder, and increasing evidence suggests that inflammatory and oxidative processes may contribute to its biological complexity. Despite these observations, no molecular biomarker has yet been established for clinical diagnosis. In this narrative review, we examine interleukin-18 (IL-18) and the NFE2L2/NRF2 antioxidant pathway as two potentially complementary components of the inflammation-redox landscape in…
